Harper, T. A., Bacot, S. M., Fennell, C. J., Matthews, R. L., Zhu, C., Yue, P., . . . Feldman, G. M. (2021). IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses. MDPI AG.
Chicago Style (17th ed.) CitationHarper, Taylor A., et al. IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses. MDPI AG, 2021.
MLA (8th ed.) CitationHarper, Taylor A., et al. IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.